Kiadis Raises €28m As Cell Therapy Nears Commercialization
The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.
The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.